BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 23765698)

  • 21. Medical management of nocturnal enuresis.
    Deshpande AV; Caldwell PH
    Paediatr Drugs; 2012 Apr; 14(2):71-7. PubMed ID: 22168597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of desmopressin and enuresis alarm as first and second line treatment for primary monosymptomatic nocturnal enuresis: prospective randomized crossover study.
    Kwak KW; Lee YS; Park KH; Baek M
    J Urol; 2010 Dec; 184(6):2521-6. PubMed ID: 20961574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nocturnal enuresis: application of evidence-based medicine in community practice.
    Cutting DA; Pallant JF; Cutting FM
    J Paediatr Child Health; 2007 Mar; 43(3):167-72. PubMed ID: 17316191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tailoring treatment of monosymptomatic nocturnal enuresis: the role of maximum voided capacity.
    Tauris LH; Kamperis K; Hagstroem S; Bower WF; Rittig S
    J Urol; 2012 Feb; 187(2):664-9. PubMed ID: 22177206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monosymptomatic nocturnal enuresis in pediatric patients: multidisciplinary assessment and effects of therapeutic intervention.
    Fagundes SN; Lebl AS; Azevedo Soster L; Sousa E Silva GJ; Silvares EF; Koch VH
    Pediatr Nephrol; 2017 May; 32(5):843-851. PubMed ID: 27988804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of desmopressin on renal water and solute handling in desmopressin resistant monosymptomatic nocturnal enuresis.
    Kamperis K; Rittig S; Radvanska E; Jørgensen KA; Djurhuus JC
    J Urol; 2008 Aug; 180(2):707-13; discussion 713-4. PubMed ID: 18554642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nocturnal enuresis.
    Thiedke CC
    Am Fam Physician; 2003 Apr; 67(7):1499-506. PubMed ID: 12722850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating nocturnal enuresis in children in primary care.
    Bottomley G
    Practitioner; 2011 Jun; 255(1741):23-6, 2-3. PubMed ID: 21776914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of nocturnal enuresis in children with attention deficit hyperactivity disorder.
    Chertin B; Koulikov D; Abu-Arafeh W; Mor Y; Shenfeld OZ; Farkas A
    J Urol; 2007 Oct; 178(4 Pt 2):1744-7. PubMed ID: 17707010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Desmopressin versus desmopressin + oxybutynin in the treatment of children with nocturnal enuresis.
    Gözüküçük A; Kılıç M; Çakıroğlu B
    J Pediatr Urol; 2021 Aug; 17(4):451.e1-451.e6. PubMed ID: 33931318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can urinary nerve growth factor and bladder wall thickness correlation in children have a potential role to predict the outcome of non-monosymptomatic nocturnal enuresis?
    Telli O; Samancı C; Sarıcı H; Hascıcek AM; Kabar M; Eroglu M
    J Pediatr Urol; 2015 Oct; 11(5):265.e1-5. PubMed ID: 26051999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow-up of enuretic alarm treatment in enuresis nocturna.
    Tuncel A; Mavituna I; Nalcacioglu V; Tekdogan U; Uzun B; Atan A
    Scand J Urol Nephrol; 2008; 42(5):449-54. PubMed ID: 18609270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of an enuresis alarm in monosymptomatic nocturnal enuresis.
    Ozgür BC; Ozgür S; Doğan V; Orün UA
    Singapore Med J; 2009 Sep; 50(9):879-80. PubMed ID: 19787175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues.
    Van de Walle J; Van Herzeele C; Raes A
    Drug Saf; 2010 Apr; 33(4):261-71. PubMed ID: 20297859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of treatments for nocturnal enuresis in a heterogeneous population.
    Schulman SL; Colish Y; von Zuben FC; Kodman-Jones C
    Clin Pediatr (Phila); 2000 Jun; 39(6):359-64. PubMed ID: 10879938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial combination therapy with desmopressin, solifenacin, and alarm for monosymptomatic nocturnal enuresis.
    Fujinaga S; Nishizaki N; Ohtomo Y
    Pediatr Int; 2017 Mar; 59(3):383-384. PubMed ID: 28317303
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of Urinary Aquaporin 2 and Plasma Copeptin as Biomarkers of Effectiveness of Desmopressin Acetate for the Treatment of Monosymptomatic Nocturnal Enuresis.
    Hara T; Ohtomo Y; Endo A; Niijima S; Yasui M; Shimizu T
    J Urol; 2017 Oct; 198(4):921-927. PubMed ID: 28457803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure of monotherapy in primary monosymptomatic enuresis: a combined desmopressin and propiverine treatment regimen improves efficacy outcomes.
    Alloussi SH; Mürtz G; Gitzhofer S; Eichel R; Lang C; Madersbacher H; Strugala G; Alloussi S
    BJU Int; 2009 Jun; 103(12):1706-12. PubMed ID: 19154456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation of subgroups of monosymptomatic enuresis according to prepulse inhibition of the startle reflex.
    Eggert P; Freischmidt S; Bismarck PV; Schulz-Jürgensen S
    Acta Paediatr; 2012 Jul; 101(7):e304-8. PubMed ID: 22360321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Office management of pediatric primary nocturnal enuresis: a comparison of physician advised and parent chosen alternative treatment outcomes.
    Diaz Saldano D; Chaviano AH; Maizels M; Yerkes EB; Cheng EY; Losavio J; Porten SP; Sullivan C; Zebold KF; Hagerty J; Kaplan WE
    J Urol; 2007 Oct; 178(4 Pt 2):1758-61; discussion 1762. PubMed ID: 17707433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.